Report Categories
View AllRecent Articles
View All
IMUX Immunic EPS beats estimates by 27 despite zero revenue yet stock slides on pipeline concerns
Great Elm GECCG Stock Moving Higher Breakout Watch 20260418
Red Rock RRR Volume Analysis Red Rock Resorts posts 215 pct EPS beat on strong leisure demand
What to expect from CryoPort CYRX stock in the coming months Slow Grind 20260420
Agnico Eagle Mines Limited AEM Closes Strategic Equity Investment in Cascadia Minerals to Expand Critical Minerals Exposure
Invesco CurrencyShares Euro Trust FXE Bullish Momentum Set to Extend Amid Sustained Euro Appreciation and Shifting Global Reserve Dynamics
Is Urban Outfitters URBN stock failing to hold levels Market Focus 20260420
Trumps Palantir Stock Trades and Social Media Endorsement Draw Scrutiny
Culp CULP Q1 2026 Earnings Miss by Significant Key Takeaways
Delta Air DAL Q1 2026 Earnings Surprise EPS 064 Up Significant
Rein Therapeutics RNTX Stock Today Drops 095 Key Support at 099 20260518
Covista CVSA Q1 2026 Earnings EPS 198 Beats Estimates
Sezzle SEZL Stock Analysis 387 Gain What to Watch 20260518
Deutsche Bank Maintains Positive Stance on Salesforce as Citi Adjusts Price Target Lower
SpaceX IPO Speculation Nvidia Earnings Bezos on AI Bubble Morning Market Digest
US CPI Report for April 2026 Released TD Economics Provides Analysis
Micron Stock Reaches 1 Trillion Mark Amid Unprecedented Political and Wall Street Support Barrons Reports
US Payrolls Beat Expectations in April but Underlying Weaknesses Raise Concerns
Indian Stock Market Sensex and Nifty 50 Outlook Amid Geopolitical Tensions Expert Views for Next Week
Precision BioSciences DTIL Q1 2026 Earnings EPS Misses Estimates as Revenue Remains Unreported Stock Edges Higher
Acorn Energy Inc ACFN Q4 2025 Earnings Positive EPS Marks a Turnaround Quarter
KRUS Q1 2026 Earnings NarrowerThanExpected Loss Boosts Sentiment
CVRX Q1 2026 Earnings EPS Beat Driven by Cost Discipline Despite Uncertain Revenue Trajectory
Ituran ITRN Q4 2025 Earnings EPS Slightly Beats Estimates Amid Positive Stock Movement
JPM Q1 2026 Earnings EPS Beats Estimates by Nearly 8 as Strong Trading and Investment Banking Results Drive Performance
International Flavors Fragrances IFF Edges Higher Testing Key Resistance After 134 Gain
UMB Financial Slides 162 Support Levels Tested Amid Sector Weakness
Royalty Pharma RPRX Gains 177 as Stock Tests MidRange Levels
X4 Pharmaceuticals XFOR Gains 273 as Stock Tests Key Resistance Levels
OptimizeRx Corporation OPRX Jumps 45 as Shares Reclaim Key Support